Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 2/2007

01-12-2007 | Case Report

Antiphospholipid syndrome: a predisposing factor for early onset HELLP syndrome

Authors: Panagiotis Tsirigotis, George Mantzios, Vassiliki Pappa, Konstantinos Girkas, George Salamalekis, Angellos Koutras, Vassiliki Giannopoulou, Konstantina Spirou, Alexia Balanika, Sotirios Papageorgiou, Anthi Travlou, John Dervenoulas

Published in: Rheumatology International | Issue 2/2007

Login to get access

Abstract

Hemolysis elevated liver enzymes low platelets syndrome (HELLP) is a relatively rare pregnancy-related thrombotic microangiopathic disorder, usually observed during the third trimester. Its incidence seems to be increased in patients with antiphospholipid syndrome (APS). In this report, we describe a 33-year-old pregnant woman with previously known primary APS who developed early onset HELLP syndrome during the 15th week of gestation. We also review the literature about this interesting relationship between APS and HELLP.
Literature
1.
Vora S, Asherson R, Erkan D (2006) Catastrophic antiphospholipid syndrome. J Intensive Care Med 21(3):144–159PubMedCrossRef
2.
Geary M (1997) The HELLP syndrome. Br J Obstet Gynaecol 104(8):887–891PubMed
3.
Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA (1993) Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome. Am J Obstet Gynecol 169:1000–1006PubMed
4.
Kinoshita K (1993) Hepatic infarction during pregnancy complicated by antipospholipid syndrome. Am J Obstet Gynecol 169:199–202PubMed
5.
Hochfeld M, Druzin ML, Maia D, Wright J, Lambert RE, McGuire J (1994) Pregnancy complicated by primary antiphospholipid syndrome. Obstet Gynecol 83:804–805PubMed
6.
Ornstein MH, Rand JH (1994) An association between refractory HELLP syndrome and the antiphospholipid antibodies during pregnancy. A report of 2 cases. J Rheumatol 21:1360–1364PubMed
7.
Ilbery M, Jones AR, Sampson MB, Sampson J (1995) Lupus anticoagulant and HELLP syndrome complicated by placental abruption, hepatic, dermal and adrenal infarction. Aust NZ Obstet Gynecol 35:215–217
8.
Alsulyman OM, Castro MA, Zuckerman E, McGehee W, Goodwin TM (1996) Preeclampsia and liver infarction in early pregnancy associated with the antiphospholipid syndrome. Obstet Gynecol 88:644–646PubMedCrossRef
9.
Segal S, Senhav S, Segal O, Zohav E, Gemer O (1996) Budd-Chiari syndrome complicating severe preeclampsia in a parturient with primary antiphospholipid syndrome. Eur J Obstet Gynecol Reprod Biol 68:227–229PubMedCrossRef
10.
Amant F, Spitz B, Arnout J, Van Assche FA (1997) Hepatic necrosis and hemorrhage in pregnant patients with antiphospholipid antibodies. Lupus 36:552–555
11.
Nagayama K,Izumi N, Miyasaka Y, Saito K, Ono K, Nogushi O, Hoshino Y, Uchihara M, Miyake S, Enomoto N, Tanaka Y, Marumo F, Sato C (1997) Hemolysis, elevated liver enzymes and low platelets syndrome associated with primary antiphospholipid syndrome. Intern Med 36:661–666PubMed
12.
Neuwelt CM, Daikh DI, Linfoot JA, Pfister DA, Yong RG, Webb RL, London SS, Asherson RA (1997) Catastrophic antiphospholipid syndrome. Response to repeated plasmapheresis over three years. Arthitis Rheum 40:1534–1539CrossRef
13.
McMahon LP, Smith J (1997) The HELLP syndrome at 16 weeks gestation: possible association with the antiphospholipid syndrome. Aust NZ J Obstet Gynecol 37:313–314
14.
Fear T, Fathoms G, Weber C, Fontana A, Schaffer A (2001) Fetal loss, liver necrosis and acute lupus erythematosus in a patient with antiphospholipid antibody syndrome. Lupus 10:576–579CrossRef
15.
Sinha J, Chowdhry I, Sedan S, Barland P (2002) Bone marrow necrosis and refractory HELLP syndrome in a patient with catastrophic antiphospholipid antibody syndrome. J Rheumatol 29:195–197PubMed
16.
Pauzner R, Dulitzky M, Carp H, Mayan H, Kenett R, Farfel Z, Many A (2003) Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome. J Thromb Haemost 1:1758–1763PubMedCrossRef
17.
Haram K, Trovik J, Sandset PM, Hordnes K (2003) Severe syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP) in the 18th week of pregnancy associated with the antiphospholipid antibody syndrome. Acta Obstet Gynecol Scand 82:679–680PubMedCrossRef
18.
Roberts G, Gordon MM, Porter D, Jardine AG, Gibson IW (2003) Acute renal failure complicating HELLP syndrome, SLE and antiphospholipid syndrome: successful outcome using plasma exchange therapy. Lupus 12:251–257PubMedCrossRef
19.
Queyrel V, Ducloy-Bouthors AS, Michon-Pasturel U, Hachulla E, Dubucquoi S, Caron C, Vallat AS, Subtil D, Dufour P Lambert M, Hatron PY, Devulder B, Puech F (2003) Anticorps antiphospholipides au cours du syndrome HELLP: etude clinique et biologique a partir de 68 patientes. Revue Med Interne 24:158–164CrossRef
20.
Le Thi Huong D, Wechsler B, Bletry O, Vauthier-Brouzes D, Lefebvre G, Piette JC (2001) A study of 75 pregnancies in patients with the antiphospholipid syndrome. J Rheumatol 28:2025–2030
21.
Braems G, Van Renterghem N, Roelens K, Van den Broecke R, Weyers S, Temmerman M (2005) Antiphospholipid syndrome during pregnancy: associated with early onset of HELLP syndrome and liver infarctions. Eur J Obstet Gynecol Reprod Biol 123(2):255–257PubMedCrossRef
22.
Haram K, Bjorge L, Sandset PM (2005) Successful preconceptional prophylactic treatment with combined acetyl salicylic acid and low-molecular heparin (Fragmin) in a case of antiphospholipid-antibody syndrome with prior life-threatening hemolysis, elevated liver enzymes and low-platelet syndrome: a case report. Acta Obstet Gynecol Scand 84(12):1213–1214PubMedCrossRef
23.
Riviello C, Ammannati F, Lamassa M, Mariotti F, Mennonna P, Parretti E, Tondi F, Mello G (2005) Atypical onset of antiphospholipid syndrome in pregnancy: a case report. Thromb Res 115(5):405–408PubMedCrossRef
24.
Le Thi THuong D, Tieulie N, Costedoat N, Andreu MR, Wechsler B, Vauthier-Brouzes D, Aumaiter O, Piette JC (2005) The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 64(2):273–278PubMedCrossRef
25.
Koenig M, Roy M, Baccot S, Cuillerron M, de Filippis JP, Cathebras P (2005) Thrombotic microangiopathy with liver, gut and bone infarction (catastrophic antiphospholipid syndrome) associated with HELLP syndrome. Clin Rheumatol 24(2):166–168PubMedCrossRef
26.
Zissin R, Yaffe D, Fejgin M, Olsfanger D, Shapiro-Feinberg M (1999) Hepatic infarction in preeclampsia as part of the HELLP syndrome: CT appearance. Abdom Imaging 24:594–596PubMedCrossRef
Metadata
Title
Antiphospholipid syndrome: a predisposing factor for early onset HELLP syndrome
Authors
Panagiotis Tsirigotis
George Mantzios
Vassiliki Pappa
Konstantinos Girkas
George Salamalekis
Angellos Koutras
Vassiliki Giannopoulou
Konstantina Spirou
Alexia Balanika
Sotirios Papageorgiou
Anthi Travlou
John Dervenoulas
Publication date
01-12-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 2/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0386-6

Other articles of this Issue 2/2007

Rheumatology International 2/2007 Go to the issue

Case Report

Successful treatment with rituximab in a patient with mental nerve neuropathy in primary Sjögren’s syndrome

Original Article

Microvascular dysfunction in rheumatoid arthritis assessed by laser Doppler anemometry: relationship to soluble adhesion molecules and extraarticular manifestations

Case Report

A novel mutation of the familial Mediterranean fever gene in a Greek family related to a non-classical, variably expressed FMF phenotype

Preliminary Results

Tumour necrosis factor a −308 promoter polymorphism in patients with rheumatoid arthritis

Case Report

Hodgkin’s lymphoma following treatment with etanercept in ankylosing spondylitis

Case Report

Successful rituximab-CHOP treatment of systemic lupus erythematosus associated with diffuse large B-cell non-Hodgkin lymphoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits